ya true but you know with the ohm list of 90 poten

ya true but you know with the ohm list of 90 potential treatments for leronlimab and where our current sub dollar price is a buyout would make more sense for a big spending bp cos.imagine gilead pays $21 billion to get their hands on trodelvy immu but leronlimab is a way bigger bang for the buck. just a theory a partnership
works too for me.